The Double Helix, Spring 2022
Spring 2022 issue of quarterly NFID eNewsletter covering:
- The impacts of COVID-19 on vaccine research
- 2022 Annual Conference on Vaccinology Research (Online)
- Respiratory syncytial virus (RSV)
- Influenza (flu)
- Partner News
- More …
Message From Headquarters
COVID-19 has had an impact on all of us, both personally and professionally—including the focus of the Annual Conference on Vaccinology Research, which the National Foundation for Infectious Diseases (NFID) has hosted for more than 25 years. During the 2022 online conference next month, leading experts will explore the future of vaccinology research, addressing scientific challenges as well as the global threat of vaccine hesitancy. I hope to ‘see’ many of you there. COVID-19 experiences have taught us much about developing more effective vaccines, and some of these lessons may apply to respiratory syncytial virus (RSV) …
Related Posts
The Double Helix, Spring 2024
Spring 2024 issue of quarterly NFID eNewsletter covering: Measles resurgence Addressing gaps in vaccine access and coverage 2024 Annual Conference on Vaccinology Research NFID Resources…
The Double Helix, Winter 2023
Winter 2023 issue of quarterly NFID eNewsletter covering: 2023 Impact Report 2024 NFID Awards Nominations 2024 Annual Conference on Vaccinology Research Call for Abstracts Clinical…
The Double Helix, Fall 2023
Fall 2023 issue of quarterly NFID eNewsletter covering: NFID National Survey: Attitudes about Respiratory Diseases 2023 Annual News Conference Online Clinical Vaccinology Course 50th Anniversary…